{
  "ptid_time": "007_S_4620_2019-12-11",
  "img_path": "/data/qiuhui/data/adni/images/007_S_4620/2019-12-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 58,165 mm³, 23.7% above the reference mean. With a Z-score of 0.69 (75.5th percentile), this represents normal volume ; hippocampal volume measures 6,002 mm³, 13.9% below the reference mean. With a Z-score of -1.20 (11.5th percentile), this represents mild atrophy; whole brain volume measures 929,274 mm³, 9.7% below the reference mean. With a Z-score of -1.27 (10.2th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,117 mm³, 21.5% below the reference mean. With a Z-score of -1.41 (8.0th percentile), this represents mild atrophy; fusiform gyrus volume measures 17,394 mm³, 3.7% below the reference mean. With a Z-score of -0.32 (37.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,886 mm³, 1.4% below the reference mean. With a Z-score of -0.13 (44.9th percentile), this represents normal volume . ",
  "text_data": "Age is 84.6 years. Gender is Male. Education: 19 years. MMSE: 27.0. MoCA: 25.0. Logical Memory: 9.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.39 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild atrophy in the hippocampus, whole brain, and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD). However, cognitive scores (MMSE 27, MoCA 25) are within normal limits for age, and there is no APOE4 risk allele. Elevated AV45 (amyloid PET) suggests amyloid pathology, but clinical symptoms are absent.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive but cognitively stable)  \n**Confidence:** **Medium** (imaging supports neurodegeneration, but cognitive performance is preserved, and APOE4 status is negative).",
  "timestamp": "2025-07-25T22:05:16.814247"
}